Total Funding
6
Total FundingSeries A raised
Growth Score
pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
122478
Attenua, Inc. is a pharmaceutical company developing antitussive (anti-cough) medications.
Acquired by 
CODA Biotherapeutics
About the Company
Attenua, Inc. is a virtual biotech company formed to develop therapies for debilitating conditions neglected by Big Pharma's shift to specialty Pharma and biologics. They believe small molecule Blockbuster drugs that would benefit millions are still to be discovered.
They have assembled a team of leading scientists and ex-Big Pharma advisors
with many years of drug development expertise. Their team has previous work experience at Merck, GSK, AstraZeneca, and Genentech.
